266 related articles for article (PubMed ID: 8898337)
1. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.
Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T
Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337
[TBL] [Abstract][Full Text] [Related]
2. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
3. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
[TBL] [Abstract][Full Text] [Related]
4. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
6. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
7. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Malar J; 2011 May; 10():119. PubMed ID: 21554743
[TBL] [Abstract][Full Text] [Related]
8. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Cortese JF; Plowe CV
Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate.
Nzila A; Rottmann M; Chitnumsub P; Kiara SM; Kamchonwongpaisan S; Maneeruttanarungroj C; Taweechai S; Yeung BK; Goh A; Lakshminarayana SB; Zou B; Wong J; Ma NL; Weaver M; Keller TH; Dartois V; Wittlin S; Brun R; Yuthavong Y; Diagana TT
Antimicrob Agents Chemother; 2010 Jun; 54(6):2603-10. PubMed ID: 20350951
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
[TBL] [Abstract][Full Text] [Related]
12. Basis for antifolate action and resistance in malaria.
Yuthavong Y
Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
[TBL] [Abstract][Full Text] [Related]
13. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites.
Hyde JE
Pharmacol Ther; 1990; 48(1):45-59. PubMed ID: 2274577
[TBL] [Abstract][Full Text] [Related]
14. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
[TBL] [Abstract][Full Text] [Related]
16. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
17. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
[TBL] [Abstract][Full Text] [Related]
18. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
[TBL] [Abstract][Full Text] [Related]
19. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]